Evidence map›Paper›PMID 35335969›Full record

ArticlePharmaceutics2022

Synthesis and Evaluation of the Antifungal and Toxicological Activity of Nitrofuran Derivatives.

Carolina Orlando Vaso, Fabiana Pandolfi, Níura Madalena Bila, Daniela De Vita, Martina Bortolami, Maria José Soares Mendes-Giannini, Valeria Tudino, Roberta Costi, Caroline Barcelos Costa-Orlandi, Ana Marisa Fusco-Almeida and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Peptides fromFuture microbiology · 2025
    Article
  4. Article
  5. Evaluation of the Anti-Pharmaceutics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Carolina Orlando VasoSchool of Pharmaceutical Science, Universidade Estadual Paulista, Araraquara 14800-903, SP, Brazil.ORCID 0000-0002-4629-680X
Fabiana PandolfiDepartment of Scienze di Base e Applicate per l'Ingegneria, Sapienza University of Rome, Via Castro Laurenziano 7, 00185 Rome, Italy.
Níura Madalena BilaSchool of Pharmaceutical Science, Universidade Estadual Paulista, Araraquara 14800-903, SP, Brazil.
Daniela De VitaDepartment of Environmental Biology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
Martina BortolamiDepartment of Scienze di Base e Applicate per l'Ingegneria, Sapienza University of Rome, Via Castro Laurenziano 7, 00185 Rome, Italy.ORCID 0000-0001-5740-6499
Maria José Soares Mendes-GianniniSchool of Pharmaceutical Science, Universidade Estadual Paulista, Araraquara 14800-903, SP, Brazil.ORCID 0000-0002-8059-0826
Valeria TudinoDepartment of Chimica e Tecnologia del Farmaco, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
Roberta CostiDepartment of Chemistry and Technology of Drug, Instituto Pasteur, Fondazione Cenci Bolognetti, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
Caroline Barcelos Costa-OrlandiSchool of Pharmaceutical Science, Universidade Estadual Paulista, Araraquara 14800-903, SP, Brazil.ORCID 0000-0002-5752-6367
Ana Marisa Fusco-AlmeidaSchool of Pharmaceutical Science, Universidade Estadual Paulista, Araraquara 14800-903, SP, Brazil.
Luigi ScipioneDepartment of Chimica e Tecnologia del Farmaco, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0002-2006-7005

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 134559/2018-5 (COV)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 142049/2019- 0 (NMB)Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP 16/11836-0 (MJSM-G)Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP 2017/18388-6 (CBC-O)Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP 2019/22188-8 (NMB)Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP 2020/15586-4 (COV)Programa de Apoio ao Desenvolvimento Científico (PADC) da Faculdade de Ciências Farmacêuticas da UNESP, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) 001; 88887.500765/2020-00 (COV)
6 · The paper itself

Abstract

Fungal diseases affect more than 1 billion people worldwide. The constant global changes, the advent of new pandemics, and chronic diseases favor the diffusion of fungal pathogens such as

Indexed as

antifungal activitybroad-spectrum antifungalCaenorhabditis elegans larvaeCandida sp.Cryptococcus neoformansHistoplasma capsulatumnitrofuran derivatesParacoccidioides brasiliensisTrichophyton mentagrophytesTrichophyton rubrum

Identifiers

PMID35335969
PMCPMC8950151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.